Dr Lipin Loo received his PhD in Pharmacology from University of Iowa in 2013. He received postdoctoral training in the Zylka lab at the Neuroscience Center of University of North Carolina from 2014 to 2017. Lipin joined University of Sydney in 2018 as Dr John and Anne Chong Genome Editing and Stem Cell Research Fellow and his primary interest is leveraging functional genomics to define the underlying principles that control human biology and disease. Lipin is now a Group Leader in RNA Therapies and also co-leads the Single Cell Biology node at the Charles Perkins Centre.